Objective: To assess the use of analgesia guidelines for newborn infants in the United Kingdom.
Introduction
Sick and premature infants may suffer repeated painful stimuli during their stay in hospital. Until relatively recently pain in the newborn was seen as an inevitable part of neonatal care and either ignored or denied. Pain and stress experienced in the newborn period may have short-and long-term adverse effects. [1] [2] [3] Consequences in the short term include altered patterns of behavior 4 and changes in physiological parameters. 5 In the long-term infants have been shown to have an altered response to pain. 6 Alleviating potentially painful or stressful events may lead to a better medical and neurodevelopmental outcome. 7 A growing body of evidence has led to increasing awareness of the importance of pain relief. National surveys from the United Kingdom, Italy and Australia have shown that despite this, the routine use of analgesia for procedural pain is still poor. 8, 9 The aim of our study was to establish the current state of pain management across the United Kingdom for procedures commonly performed in neonatal nurseries.
Methods

A national survey of procedural pain management in the United
Kingdom was conducted in April 2005. A questionnaire was written by the authors and piloted in our own unit before posting to every unit providing newborn care in the United Kingdom. Unit details were taken from the Directory of Critical Care. 10 The questionnaire was anonymous and sent to the lead nurse in each unit with a reply paid envelope to encourage return. A reminder letter and duplicate survey was sent out 6 weeks later in June 2005.
The survey comprised an introductory section requesting the job title of the respondent and the maximum level of care the unit provided to the newborn. The levels used were as defined by the British Association of Perinatal Medicine 11 (BAPM). Level 1 Units provide Special Care but do not aim to provide any continuing High Dependency or Intensive Care. This term includes units with or without resident medical staff. Level 2 Units provide High Dependency Care and some short-term Intensive Care as agreed within the network. Level 3 Units provide the whole range of medical neonatal care but not necessarily all specialist services such as neonatal surgery.
The rest of the three-page survey was divided into six sections asking for information on current guidelines for the management of elective intubation, mechanical ventilation, management of painful conditions, post-operative pain relief and minor procedural pain on the neonatal unit and postnatal wards. Specifically, for each area information was requested on the existence of a guideline for the procedure (written or otherwise) and the drugs used. Examples of conditions or procedures were given; painful conditions included necrotizing enterocolitis (NEC), incarcerated hernia and minor procedures were cannulation, heel prick (stabs) and long lines. Within the minor procedure section topical anesthesia and sweet-tasting solution were specifically asked about (agent used, concentration used, gestation applied to and contraindications). Other non-pharmacological interventions were asked about and finally a free text section was available for comments.
As this was an observational study, no statistical analysis was performed. The free text section of the questionnaire was analyzed using accepted qualitative research methods.
Results
A total number of 244 units were sent a questionnaire. One hundred and ninety-two replies were received (78.7% response rate). The replies came from all levels of units ( Figure 1) . One unit had closed down. The results are calculated from the information gained from units that replied. All units replying to the survey answered all questions.
Sedation for ventilation
Of those units that replied 149 (77.6%) units had a guideline for the sedation/analgesia of infants receiving mechanical ventilation. This included 27 (75%) of level 1 Units, 66 (67%) of level 2 Units and 50 (66%) of level 3 Units. Of the total number of units who had a guideline 109 (73.1%) were formalized written guidelines. Four different drugs were used ( Figure 1 ). Some units named a combination of drugs. Within the different levels of unit the presence of a guideline was fairly consistent (67% (range 60 to 76%)) except for level 3 Units offering neonatal surgery 85% of which had a guideline.
Elective intubation
One hundred and thirty-five units had a sedation/pain relief guideline (70.3%) for the non-urgent intubation of infants and 89 (65.9%) of these were written documents. Of the units that replied 58.8% (range 54 to 66%) of each level had a guideline, except level 3 Surgical Units; 95% of these units had a guideline. There were a variety of sedating ( Figure 1 ) and muscle relaxing ( Figure 2 ) drugs used and 31 units (16%) used atropine in combination with a sedative and muscle relaxant. The most common combination of drugs was morphine, suxamethonium and atropine (29 units (15%)) (Figures 2 and 3 ).
Post-operative pain relief
Of the units providing surgical services 14 (74%) had guidelines for the management of post-operative pain relief. Five surgical units (26%) had no guideline for this condition. Of the units with guidelines 50% had written documents. Morphine was the first-line drug in 29 units (93.5% of units with guidelines) and diamorphine in 2 (6.5%). Other drugs used include midazolam, fentanyl, codeine, paracetamol and ibuprofen.
Management of painful conditions
Seventy-eight (40.1%) replies had a guideline for the relief of pain and distress in conditions such as NEC and incarcerated herniae. In 32 (41.0%) of units this was a formal written document. Ten (5.2%) units felt that a guideline for the management of painful conditions was not applicable to their unit. These were all level 1 and 2 Units. All units used morphine with five (6.4%) units also occasionally using diamorphine. Minor procedures For common, short but painful procedures carried out regularly on the neonatal unit or postnatal wards 67 units that replied (34.9%) had guidelines for pain relief. Fifty-three (79.1%) of these guidelines were written. Twenty-three (12.0%) units used topical anesthetic creams; 6 (26.1%) using a lidocaine/prilocaine cream and 17 (73.9%) amethocaine 4% cream. There was a wide variation in the lowest gestation of infants that the cream was used on from <26 weeks to 3 months post-term (median 34 weeks).
Sucrose or other sweet-tasting solutions Sixty-three (32.8%) units providing newborn care at any level used sucrose or other sweet-tasting solutions for analgesia before common painful procedures. Two units used Hypostop (40% glucose gel) and 10 used dextrose. All other units used varying concentrations of sucrose the most common being 24% (25 units) (range 12 to 66% sucrose).
There was a wide variation in the lowest gestation at which the sweet solution could be given from 'any gestation' (two units) to 35 weeks (mean 28 weeks; median 28 weeks). Contraindications to using a buccal sweet-tasting solution were most commonly necrotizing enterocolitis, nil by mouth (npo) or ventilated. All units that administer sweet tasting solutions for pain relief used it for the common procedures listed in the questionnaire (heel pricks, immunization, blood sampling and cannulation) and some units offered additional information recommending its use for retinopathy screening.
Other measures
Other comforting techniques such as swaddling, non-nutritive sucking, breast-feeding or environmental measures (low lighting and low noise levels) were employed by most units (153 (79.7%) ).
Non-nutritive sucking and swaddling were the most commonly used measured.
Discussion
It is commonplace for infants in neonatal units to undergo painful procedures, often several times a day if the infant is sick. There is a growing body of evidence that shows that the pain and distress in the newborn period can have short-and long-term effects. Our questionnaire survey was developed by both authors and piloted among local units. Some minor changes were made as a result of the pilot evaluation to clarify the information we sought. It was then sent to every unit providing newborn care in the United Kingdom. To the best of our knowledge this makes it the largest survey of its kind in Britain. Although the response rate (72%) for a postal survey is good the non-responders may potentially contribute to some bias in reporting, but there was the same proportion of non-responders in each level of care nursery so there is unlikely to be a systematic bias in the data. The data were reported by a single person (lead nurse) from each unit and this may also have introduced bias, which again may have affected our results, but it was our opinion that the lead nurse was best placed to be aware of the latest guidelines in their unit. Despite this, our results show that the utilization of pain relief measures in newborn care across the United Kingdom remains poor.
In 2000, Sabrine and Sinha 12 reported on pain management in 86 units across the United Kingdom. Only 5% of units routinely used analgesia for common procedures such as venepuncture, long line insertion and cannulation. In Australia, in 2004, results of a survey showed 15% of units have guidelines for pain relief and 23% used sucrose. Our results show 35% of units were using analgesia for procedural pain. While it is encouraging that more units are using analgesia than in 2000, we are still clearly not taking heed of the evidence and treating neonatal pain well enough.
Two large international groups 13, 14 have produced guidelines endorsed by the American Academy of Pediatrics, for the management of pain and stress in the newborn and there is now abundant literature on the use of topical anesthesia and sweet-tasting solutions. Topical anesthesia is safe, effective in premature infants as well as cheap. [15] [16] [17] [18] [19] [20] [21] [22] [23] However, only 12% of units in our survey use it. Likewise, there is high-level evidence 24 on the efficacy and safety of sucrose as analgesia but it is only used in 32.8% of units. Our results do reflect the lack of evidence regarding the optimum concentration or gestation at which to administer it.
The use of other measures is reported to be very high in our survey and that is encouraging. Breast-feeding as a means of pain reduction has been shown to be useful 25 but is not always possible in the neonatal intensive care setting. It is therefore important that other measures are sought to reduce the adverse effects of pain on this population. For more invasive procedures such as non-emergency intubation, this survey shows that Britain compares favorably with other such surveys from Europe and North America. 9, 26, 27 There is a wide variety of sedatives and muscle relaxants that are used and the evidence to support one over another is not available. The NEOPAIN study 28 showed that morphine sedation for the perceived discomfort and stress of ventilation in preterm infants was not associated with better outcomes. The authors suggest the use of pain assessment tools should be more widely used and analgesia titrated to the results. We did not ask specifically about the use of pain assessment tools but only 6% of units in the Australian survey used them regularly. There are many different validated tools available although relating the tools to pain management strategies is an area lacking in evidence.
The reason that clinicians are so slow at taking up the routine use of analgesia is not clear when well-designed studies show a clear benefit to patients. Despite the wealth of evidence the application of this knowledge in practice is still not widespread. Unfortunately, the situation where good evidence for effective treatment is available but not practised routinely for many years has been frequently repeated. The discovery by Liggins in 1969 that glucocorticoids reduced lung disease in preterm lambs took over 20 years to be translated into the routine medical practice of antenatal steroids for threatened preterm delivery.
Assessing the degree of discomfort and pain an infant feels can be a difficult skill. Neonates do not vocally complain, their reactions to pain are not immediately recognizable and it may be seen to be quicker and easier to overpower the small and weak infant. However, in the modern era with the ever-growing body of evidence our care must be more holistic. Effective pain relief has been shown to incur positive benefits on both the infant and the health-care provider.
Many units with comprehensive pain relief guidelines commented that continual education and training of the staff delivering the pharmacological and non-pharmacological analgesic measures was essential to success. Turnover of staff in neonatal units tends to be rapid and so knowledge may dissipate quickly. The knowledge transfer may be optimized by focussing on continuing education of the adult learner and the implementation of written guidelines and best evidence within the context of patient outcomes and quality improvement. 29 Many educational models are available to be used but a combination of theory and then practical application is probably most useful in this setting. We found that many units had unwritten 'guidelines' which we feel is inappropriate because non-written guidelines must be passed on by word of mouth which is unreliable and subject to error when many people are involved. We recommend that all units have carefully written evidence-based guidelines readily available to all staff and particularly new staff.
While we have much in the way of evidence on which to base our practice there is a need for further research. Areas to be explored include new drugs and pain relief agents, the optimum doses for our populations and the safety and efficacy of the drugs in current use. Integrating the pain assessment tools to pain management strategies should also be explored along with the use of developmental care packages that may well improve the longterm outcome of our babies.
Conclusion
There is good quality evidence that pain relief is effective and probably beneficial to the baby. Through education and training the use of simple and effective measures for pain relief in the newborn can be brought into wider practice to the benefit of the infant.
